Univdatos Whatsapp

Global Herpes Zoster Treatment Market is expected to foresee significant growth. North America to lead the growth!

The Global Herpes Zoster Treatment Market is expected to grow at a CAGR of 4%, during the forecast period.  Shingles (herpes zoster) is a viral infection that causes an outbreak of a painful rash or blisters on the skin. It’s caused by the varicella-zoster virus, which is the same virus that causes chickenpox. It is a common disease in immunocompromised individuals and in the old-aged population. In this disease, the chickenpox virus becomes dormant and re-activates when immunity compromises. The rising geriatric population is one of the important factors that is responsible for the increasing cases of shingles. For instance, as per the WHO, Between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12% to 22%. Therefore, increasing demand for effective treatment is expected to drive the global herpes zoster treatment market at a significant CAGR during the forecast period. 

 For a detailed analysis of the global herpes zoster treatment market browse throughhttps://univdatos.com/report/herpes-zoster-treatment-market/

Based on the treatment type, the market has been categorized into antiviral medications, anti-inflammatory medications, and others. Among them, the antiviral category is expected to witness lucrative growth during the forecast period. Active participation of the government in the vaccination programs and the rising demand for antiviral drugs are attributed to the growth of the segment in the herpes zoster treatment market. For instance, In 2013, the Shingles National Immunization Programme was introduced by the U.K. Department of Health. In September 2020, all eligible 70 to 79-year-olds were included in the program.

Based on the route of administration, the market has been categorized into oral, topical, and others. Among them, the oral segment is expected to have significant growth in the market. The rising demand for an effective and easier route of administration is catalyzing the market growth of oral drugs. Furthermore, increasing the adoption of antiviral drugs is also an important factor that affects the market for oral drugs.

Based on the distribution channel, the market is segmented into retail pharmacies, online pharmacies, hospital pharmacies, and others. Hospital pharmacies are expected to witness lucrative growth during the forecast period. This is mainly due to the rising number of hospitalization cases and the increasing number of old-aged patients affected by the disease. For instance, the Canadian Institute of Health Information, the hospitalization rate was 6,687 per 100,000 in 2020–2021.

Request for a sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=28000

For a better understanding of the market adoption of the herpes zoster treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America constitutes a significant herpes zoster treatment market due to the increasing R&D activities for developing a better and rising geriatric population in the region. Furthermore, the rise the public awareness about the severity of the disease is also responsible for the market growth of the treatment in the region. Additionally, the presence of developed nations such as the U.S in the region and their higher healthcare expenditure and better infrastructure is also responsible for the lucrative market share of the region in the shingles treatment market. For instance, U.S. health care spending grew 9.7 percent in 2020, reaching $4.1 trillion or $12,530 per person.  As a share of the nation’s Gross Domestic Product, health spending accounted for 19.7 percent.

Some of the major players operating in the market include Abbott Laboratory, Bausch Health, Cipla Inc., Camber Pharmaceuticals., GlaxoSmithKline plc, Merck, Novartis AG, Pfizer Inc., Eli Lilly and Co., and Teva Pharmaceutical Industries Ltd.

Global Herpes Zoster Treatment Market Segmentation

Market Insight, by Treatment Type

• Antiviral Medications
• Anti-inflammatory Medications
• Others

Market Insight, by Route of Administration

• Oral
• Topical
• Others

Market Insight, by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Market Insight, by Region

  • North America
    •  US
    •  Canada
    •  Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Rest of the World

Top Company Profiles

  • Abbott Laboratory
  • Bausch Health
  • Cipla Inc.
  • Camber Pharmaceuticals.
  • GlaxoSmithKline plc
  • Merck
  • Novartis AG
  • Pfizer Inc.
  • Eli Lilly and Co.
  • Teva Pharmaceutical Industries Ltd.

Leave A Comment

Select Language